Rare diseases
Investigational molecules
Locations
Back to Poland1 144 clinical trials in Gdansk, Poland across 11 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Pembrolizumab and Chemotherapy for Patients with Newly Diagnosed Classical Hodgkin Lymphoma
PolandStudy on the Safety and Effects of LY2880070 and Gemcitabine in Patients with Advanced or Metastatic Cancer, Focusing on Ovarian Cancer
PolandStudy on the Effectiveness and Safety of Glofitamab with Drug Combination for Untreated Large B-Cell Lymphoma Patients
PolandStudy on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata
PolandStudy on How Insulin Icodec and Semaglutide Help Control Blood Sugar in Patients with Type 2 Diabetes
PolandStudy of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments
PolandA Study of Long-Term Safety of Teplizumab in Children and Adolescents with Recently Diagnosed Type 1 Diabetes
PolandStudy on VE202 for Patients with Mild-to-Moderate Ulcerative Colitis
PolandStudy on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment
PolandStudy Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy
PolandStudy of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer
PolandLong-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on bladder cancer, lymphoma, and various advanced solid tumors. Studies are evaluating novel combination therapies and investigating treatments for non-small cell lung cancer.
Research includes promising approaches combining established treatments with new immunotherapy agents.
Clinical investigations targeting plaque psoriasis, genital psoriasis, and atopic dermatitis. Studies are examining oral and subcutaneous treatments for moderate to severe skin conditions.
Focus on developing targeted treatments for chronic skin conditions affecting quality of life.
Comprehensive research into obesity and weight management, including studies for patients with and without type 2 diabetes. Trials are evaluating new therapeutic approaches for weight reduction.
Investigation of innovative treatments combining lifestyle modifications with pharmaceutical interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
